Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Epanova and Omacor in T2DM with PEI
NCT02370537Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of Omega-3 carboxylic acids in hypertriglyceridemia, sponsored by AstraZeneca. Started Mar 2015; status: completed.
02
Drugs
Omega-3 carboxylic acids
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02370537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370537.